Fundz

Fortitude Biomedicines Appoints Rahul Patel as Senior Vice President of Clinical Development

PRIVATEApr 07, 2026

Position

Senior Vice President

Company

Fortitude Biomedicines

Rahul Patel
WalthamBiotechnologyHealth CareTherapeutics

Description

Fortitude Biomedicines announced the appointment of Dr. Rahul Patel as Senior Vice President of Clinical Development. This move is aimed at strengthening the leadership team and accelerating clinical efforts related to their therapeutic programs.

Quick answer

Fortitude Biomedicines Appoints Rahul Patel as Senior Vice President of Clinical Development (April 7, 2026). Fortitude Biomedicines is based in Waltham, Massachusetts, United States.

Who is the new Senior Vice President at Fortitude Biomedicines?
Fortitude Biomedicines named Rahul Patel Senior Vice President, announced April 7, 2026.
What did Fortitude Biomedicines announce on April 7, 2026?
Fortitude Biomedicines announced the appointment of Dr. Rahul Patel as Senior Vice President of Clinical Development. This move is aimed at strengthening the leadership team and accelerating clinical efforts related to their therapeutic programs.
What does Fortitude Biomedicines do?
Fortitude Biomedicines is a leading biopharmaceutical company focused on immune cell targeting biologics and molecular glue payload–enabled antibody–drug conjugates (ADCs) for the treatment of a wide range of autoimmune...
Where is Fortitude Biomedicines based?
Fortitude Biomedicines is based in Waltham, Massachusetts, United States.
Which similar companies made leadership changes around the same time?
Tenpoint Therapeutics (April 7, 2026), Byondis B.V (April 9, 2026), Cerenome, Inc. (April 9, 2026) and Pulse Biosciences, Inc. (April 9, 2026) also announced leadership changes within 45 days of Fortitude Biomedicines.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Fortitude Biomedicines, and when

A new leader at Fortitude Biomedicines brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Fortitude Biomedicines raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Fortitude Biomedicines, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Fortitude Biomedicines. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Fortitude Biomedicines

Location

Waltham, Massachusetts, United States

About

Fortitude Biomedicines is a leading biopharmaceutical company focused on immune cell targeting biologics and molecular glue payload–enabled antibody–drug conjugates (ADCs) for the treatment of a wide range of autoimmune diseases and cancers. The company harnesses proprietary technology to unlock the ability to precisely target diseases while engaging the body’s own biology. Fortitude's innovative GLUE-DACTM platform is designed to expand the therapeutic window of ADCs and overcome resistance mechanisms. The founding team includes experts with extensive experience in translational research and drug development.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Fortitude Biomedicines changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Wendi
Senior decision-maker at this company
••••••••@••••••••

See Wendi's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Fortitude Biomedicines's next move

Learn about Strategic plan

Fortitude Biomedicines changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.